Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HLA-F |
| Upstream (Parents) |
|---|
| (<<) BCL2A1 → HLA-F |
| (<<) HLA-G → HLA-F |
| (<<) IER2 → HLA-F |
| (<<) MREG → HLA-F |
| (<<) PLD3 → HLA-F |
| (<<) STAM2 → HLA-F |
| (<<) THRB → HLA-F |
| (<<) ZFP36 → HLA-F |
| Downstream (Children) |
|---|
| HLA-F → ATP2B1 (>>) |
| HLA-F → GBP2 (>>) |
| HLA-F → HLA-A (>>) |
| HLA-F → IRF1 (>>) |
| HLA-F → LRP6 (>>) |
| HLA-F → LTB (>>) |
| HLA-F → MYL7 (>>) |
| HLA-F → SMAD3 (>>) |
